Therefore, activation of PPARγ in adipocyte by the thiazolidinedione (TZD) class of insulin-sensitizing drugs (TZDs) can improve obesity and insulin sensitivity. Here, PPARG is linked to obesity due to melanocortin 4 receptor deficiency.